STOCK TITAN
  1. Home
  2. Sec-filings
  3. INFU
  4. [Form 4] InfuSystem Holdings, Inc Insider Trading Activity

InfuSystem (INFU) CEO awarded RSUs and stock options, updates share holdings

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

InfuSystem Holdings President and CEO Carrie Lachance reported new equity awards and updated holdings. She received a grant of 29,816 restricted stock units, which convert into common stock on a one-for-one basis and vest in three equal annual installments beginning on May 12, 2027. She also received a stock option covering 62,117 shares of common stock at an exercise price of $8.37 per share, expiring on May 12, 2036, vesting in four equal annual installments starting May 12, 2027. Following these awards, she directly holds 238,123 shares of InfuSystem common stock. These actions reflect compensation-related grants rather than open-market purchases or sales.

Positive

  • None.

Negative

  • None.
Insider Lachance Carrie
Role President and CEO
Type Security Shares Price Value
Grant/Award Stock Option (right to buy) 62,117 $0.00 --
Grant/Award Restricted Stock Units 29,816 $0.00 --
holding Common Stock -- -- --
Holdings After Transaction: Stock Option (right to buy) — 62,117 shares (Direct, null); Restricted Stock Units — 29,816 shares (Direct, null); Common Stock — 238,123 shares (Direct, null)
Footnotes (1)
  1. The option, representing the right to purchase a total of 62,117 shares of InfuSystem Holdings, Inc. common stock, vests in four equal annual installments beginning May 12, 2027. Restricted stock units convert into common stock on a one-for-one basis. These restricted stock units vest in three equal annual installments beginning on May 12, 2027.
RSU grant size 29,816 units Restricted stock units granted on May 12, 2026
Option grant size 62,117 shares Stock option (right to buy) granted on May 12, 2026
Option exercise price $8.37/share Conversion or exercise price for stock option
Option expiration May 12, 2036 Expiration date of stock option grant
Shares held after transactions 238,123 shares Common stock directly held following reported transactions
RSU vesting start May 12, 2027 RSUs vest in three equal annual installments from this date
Option vesting start May 12, 2027 Options vest in four equal annual installments from this date
Restricted stock units financial
"The option, representing the right to purchase a total of 62,117 shares of InfuSystem Holdings, Inc. common stock, vests in four equal annual installments beginning May 12, 2027."
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
Stock Option (right to buy) financial
"The option, representing the right to purchase a total of 62,117 shares of InfuSystem Holdings, Inc. common stock, vests in four equal annual installments beginning May 12, 2027."
vests in four equal annual installments financial
"The option, representing the right to purchase a total of 62,117 shares of InfuSystem Holdings, Inc. common stock, vests in four equal annual installments beginning May 12, 2027."
convert into common stock on a one-for-one basis financial
"Restricted stock units convert into common stock on a one-for-one basis."
vest in three equal annual installments financial
"These restricted stock units vest in three equal annual installments beginning on May 12, 2027."
Form 4 Insider Transactions: What Each Field Means →
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Lachance Carrie
(Last)(First)(Middle)
C/O INFUSYSTEM HOLDINGS, INC.
3851 WEST HAMLIN ROAD
(Street)
ROCHESTER HILLS MICHIGAN 48309
(City)(State)(Zip)
UNITED STATES
(Country)		2. Issuer Name and Ticker or Trading Symbol
InfuSystem Holdings, Inc [ INFU ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
XOfficer (give title below)Other (specify below)
President and CEO
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
05/12/2026		6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock238,123D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Stock Option (right to buy)$8.3705/12/2026A62,117 (1)05/12/2036Common Stock62,117$062,117D
Restricted Stock Units(2)05/12/2026A29,816 (3)05/12/2029Common Stock29,816$029,816D
Explanation of Responses:
1. The option, representing the right to purchase a total of 62,117 shares of InfuSystem Holdings, Inc. common stock, vests in four equal annual installments beginning May 12, 2027.
2. Restricted stock units convert into common stock on a one-for-one basis.
3. These restricted stock units vest in three equal annual installments beginning on May 12, 2027.
Remarks:
/s/ Kevin Whitman, Attorney-in-Fact for Carrie Lachance05/14/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What equity awards did InfuSystem (INFU) CEO Carrie Lachance receive?

Carrie Lachance received 29,816 restricted stock units and a stock option for 62,117 shares. The RSUs convert one-for-one into common stock, and both awards vest over multiple years starting in 2027 as part of her compensation.

How do Carrie Lachance’s new InfuSystem (INFU) stock options work?

She received a stock option for 62,117 InfuSystem common shares at an exercise price of $8.37 per share. The option expires on May 12, 2036 and vests in four equal annual installments beginning May 12, 2027.

When do Carrie Lachance’s new InfuSystem (INFU) RSUs vest?

The 29,816 restricted stock units vest in three equal annual installments starting May 12, 2027. Once vested, each RSU converts into one share of InfuSystem common stock, increasing her direct equity exposure over time.

Did InfuSystem (INFU) CEO Carrie Lachance buy or sell shares in this Form 4?

The Form 4 shows compensation-related grants, not open-market trades. It reports new restricted stock units and stock options awarded to her, plus an updated total of 238,123 directly held common shares after these awards.

How many InfuSystem (INFU) shares does Carrie Lachance hold after these awards?

After the reported transactions, she directly holds 238,123 shares of InfuSystem common stock. This figure excludes the 29,816 restricted stock units and 62,117 stock options, which may add to her ownership as they vest and are exercised.